Ki67 and proliferation in breast cancer. J. Clin. Pathol. 66, 512-516.Pathmanathan N, Balleine RL (2013). Ki67 and proliferation in breast cancer. J Clin Pathol 66:512-516.Ki67 and proliferation in breast cancer. Nirmala Pathmanathan,Rosemary L Balleine. Journal of Clinical Pathology . ...
[5]Liu P, Sun YL, Du J, et al. CD105/Ki67 coexpression correlates with tumorprogression and poor prognosis in epithelial ovarian cancer. Int J GynecolCancer, 2012, 22(4): 586-592. [6]Pathmanathan N, Balleine...
Background:immunohistochemical (IHC) assessment of proliferation using Ki67 in breast cancer has been shown to associate with prognosis, surrogate luminal A/B calling (with progesterone receptor, PgR) and is a marker of residual risk of ...
L. Ki67 and proliferation in breast cancer. J. Clin. Pathol. 66, 512–516 (2013). Article CAS Google Scholar Cheang, M. C. et al. Ki-67 index, Her2 status, and prognosis of patients with luminal B breast cancer. J. Natl Cancer Inst. 101, 736–750 (2009). Article CAS Google ...
Correlation of survivin, p53 and Ki-67 in laryngeal cancer Hep-2 cell proliferation and invasion of p53, Ki67 and survivin are increased in cancer; and there is a positive correlation between survivin, p53 and Ki67 expressions in laryngeal carcinoma... SG Pei,JX Wang,XL Wang,... - 《Asian...
Breast cancer (BC) is a heterogeneous disease and cell proliferation markers may help to identify subtypes of clinical interest. We here analyzed the correlation between cell proliferation determined by Ki67 and HG in BC patients undergoing preoperative chemotherapy (PCT).We obtained clinical/pathological...
Balleine Ki67 and proliferation in breast cancer J. Clin. Pathol., 66 (6) (2013), pp. 512-516 CrossrefView in ScopusGoogle Scholar [13] E. De Azambuja Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients Br. J. Canc., ...
Ki67 breast cancer neoadjuvant prediction prognosis immunohistochemistry introduction The proliferation marker Ki67 [1] has been extensively studied in breast cancer [2., 3., 4., 5., 6., 7.] and is the first immunohistochemical marker that requires an exact quantification, which is not necessary ...
An increasing number of neo-adjuvant breast cancer studies are being conducted and a novel model for tumor biological studies, the "window-of-opportunity" model, has revealed several advantages. Change in tumor cell proliferation, estimated by Ki67-expression in pre-therapeutic core biopsies versus ...
Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2 Uncontrolled cell proliferation is the hallmark of malignant tumours. Thus, the proliferative potential of tumour cells is an important prognostic factor. ... V Nguye...